72 employees
OpGen is a precision medicine company utilizing molecular diagnostics and bioinformatics to help combat infectious disease.
$2.6M sweet spot round size
Most of their 1 investments are in rounds between $2.6M and $2.6M
2002
BioRelix raised $2.6M on March 22, 2012
Investors: New Leaf Venture Partners and Whole Genome Mapping @ OpGen, Inc